Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • Polyethylenimine Linear (PEI) MW 40,000: Benchmarks & Best U

    2026-07-09

    Polyethylenimine Linear (PEI) MW 40,000: Benchmarks & Best Use

    Executive Summary: Polyethylenimine Linear (PEI), MW 40,000, is a cationic polymer essential for high-efficiency DNA delivery in mammalian cell systems, enabling transfection efficiencies of 60–80% in HEK-293, CHO-K1, HeLa, and related lines (source). Its mechanism relies on DNA condensation and cell surface charge interactions, facilitating endocytosis. PEI-mediated transfection is robust in serum-containing media and scalable from microplates to bioreactor volumes (source). The reagent is supplied by APExBIO as a ready-to-use solution for reliable, reproducible gene delivery (product page).

    Biological Rationale

    Efficient delivery of nucleic acids to mammalian cells underpins molecular biology, gene function studies, and bioproduction. Polyethylenimine Linear (PEI), MW 40,000, offers a scalable, serum-compatible transfection strategy, overcoming limitations of lipid-based or viral systems for transient gene expression (see also). This reagent is particularly relevant for the rapid production of recombinant proteins and functional genomics in research and preclinical development workflows. The ability to condense DNA and facilitate cellular uptake is critical for model systems spanning HEK-293, CHO-K1, HepG2, and HeLa cells, which are widely used in both basic and translational research (product details).

    Mechanism of Action of Polyethylenimine Linear (PEI), MW 40,000

    PEI is a polycationic polymer. Its linear form at MW 40,000 efficiently binds and condenses negatively charged DNA, forming nanoscale complexes with a net positive charge. These complexes engage with anionic cell surface proteoglycans and glycosaminoglycans, triggering uptake predominantly via endocytosis (mechanistic review). The ability to buffer endosomal pH—sometimes described as a 'proton sponge effect'—enhances endosomal escape, allowing DNA release into the cytoplasm and subsequent nuclear entry for transcription. Linear PEI is less cytotoxic and more efficient than branched analogs at comparable DNA:PEI mass ratios.

    Evidence & Benchmarks

    • PEI MW 40,000 achieves 60–80% transfection efficiency in HEK-293 and CHO-K1 cells under optimized conditions (37°C, serum-containing DMEM, 24–48 h post-transfection) (internal analysis).
    • DNA:PEI mass ratio of 1:3 (w/w) is optimal for most cell lines, balancing efficiency and viability (protocol guide).
    • Transfection is robust in the presence of 10% fetal bovine serum (FBS), with negligible drop in efficiency compared to serum-free media (application review).
    • Scalability has been demonstrated from 96-well plates (100 μL/well) to 100-liter bioreactor runs (product info).
    • Storage at -20°C is recommended for long-term stability; short-term storage at 4°C is acceptable for working stocks (product info).
    • In peer-reviewed research, PEI was used successfully to transfect primary astrocytes for mechanistic studies of neuroinflammation, as in Li et al. 2025 (DOI).

    Applications, Limits & Misconceptions

    Polyethylenimine Linear (PEI), MW 40,000, is validated for:

    • Transient gene expression in mammalian cell lines (HEK-293, CHO-K1, HeLa, HepG2).
    • Recombinant protein production at laboratory and pre-pilot scale.
    • Functional gene studies, including gene knockdown/overexpression assays.

    Compared to other reviews, this article details not only efficiency ranges but also the empirically determined boundaries and proper workflow integration for research reproducibility. For example, while PEI is effective in diverse cell lines, primary neuron cultures and certain sensitive primary cells may require further optimization or alternative reagents. This extends the guidance found in prior guides by mapping precise storage, scaling, and protocol variables.

    Common Pitfalls or Misconceptions

    • Not universally compatible: PEI MW 40,000 is not optimal for all primary cells—especially neurons or hematopoietic cells without protocol adaptation (Li et al. 2025).
    • DNA quality critical: Endotoxin-contaminated plasmid DNA can drastically reduce transfection efficiency and cell viability.
    • Overuse of PEI: Excess polymer increases cytotoxicity without improving DNA delivery; protocol-specified DNA:PEI ratios are essential (protocol guide).
    • Freeze-thaw cycles: Repeated freezing and thawing of PEI solution reduces activity; aliquot and store at recommended temperatures (product info).
    • Transfection is time/labor sensitive: Incubation time for complex formation and cell density at transfection are critical for reproducibility.

    Workflow Integration & Parameters

    • Cell seeding: Plate cells to achieve 70–80% confluence at time of transfection.
    • DNA preparation: Use plasmid DNA with A260/280 ratio ~1.8 and minimal endotoxin levels.
    • DNA:PEI complexing: Mix DNA and PEI in serum-free buffer (e.g., Opti-MEM) at a 1:3 (w/w) ratio; incubate 15–20 min at room temperature.
    • Transfection: Add complexes dropwise to cells in complete media (with or without serum).
    • Incubation: Continue incubation at 37°C, 5% CO2 for 24–48 hours.
    • Harvest: Assess expression or protein production at 24–72 hours post-transfection.
    • Scale-up protocols: For large-scale runs, maintain proportional DNA:PEI ratios, and ensure proper mixing and oxygenation in bioreactors.

    For further troubleshooting and workflow guidance, see the expanded protocols in this practical guide, which this article extends by providing peer-reviewed evidence and product-specific storage recommendations.

    Conclusion & Outlook

    Polyethylenimine Linear (PEI), MW 40,000, supplied by APExBIO, remains a gold-standard DNA transfection reagent for in vitro studies requiring high efficiency, scalability, and serum compatibility. Its robust performance is supported by quantitative benchmarks and peer-reviewed applications in diverse cell lines, including for neuroinflammation research (Li et al. 2025). Continued optimization of protocol parameters and awareness of limitations will further advance reproducible, high-yield transient gene expression and protein production workflows.